Partner with Magellan
Magellan’s machine learning is designed to extract information from large biomolecular datasets to reveal underling clinical classification
Magellan's technology analyzes an unprecedented amount of data, looking to segment patients for:
Clinical Trials
Patient selection and segmentation for clinical trials. Can be applied for new programs, or to resurrect abandoned programs
Companion Diagnostics
Identify patient signatures for responders and non-responders
Patent Extension
Extend the patent life of a program by pairing it with a new population or patient signature